2005 Clinical Trials Medicine Patients 
Cannabis Law Report
APRIL 8, 2022
as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS. Rick Doblin, Ph.D.,
Otherside Farms
JANUARY 23, 2019
International Association for Cannabis as Medicine. International Association for Cannabis as Medicine. International Association for Cannabis as Medicine. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full – 2005). abst – 2005).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TheAnswerPage
OCTOBER 27, 2021
Faculty of Medicine, The Hebrew University of Jerusalem, Member, Israel Academy of Science. whose book on medicinal plants was the leading text in pharmacology for many centuries, writes that it causes madness. Ethnopharmacology, 101, 16-26 (2005). Blog post by Professor Raphael Mechoulam. In the Jewish Talmud (300-600 C.E.)
Greencamp
FEBRUARY 2, 2019
Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. Cannabis as medicine against HIV. What is HIV and how is it manifested?
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
CannaMD
OCTOBER 7, 2019
Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?
Expert insights. Personalized for you.
52 
Let's personalize your content